Cargando…
Metabolic Factors Affecting Tumor Immunogenicity: What Is Happening at the Cellular Level?
Immunotherapy has changed the treatment paradigm in multiple solid and hematologic malignancies. However, response remains limited in a significant number of cases, with tumors developing innate or acquired resistance to checkpoint inhibition. Certain “hot” or “immune-sensitive” tumors become “cold”...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927105/ https://www.ncbi.nlm.nih.gov/pubmed/33670011 http://dx.doi.org/10.3390/ijms22042142 |